Psychopathology in women and men: Focus on female hormones

American Journal of Psychiatry

Volumn 154, Issue 12, 1997, Pages 1641-1647

  Seeman, Mary V ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; PROGESTERONE;

AFFECTIVE NEUROSIS; ALCOHOLISM; ALZHEIMER DISEASE; ANXIETY NEUROSIS; DEPRESSION; DISEASE PREDISPOSITION; FEMALE; GENDER; HORMONE RELEASE; HUMAN; MALE; MENTAL DISEASE; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA;

EID: 0030721742     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/ajp.154.12.1641     Document Type: Review

References (100)

1. Earls F: Sex differences in psychiatric disorders: origins and developmental influences. Psychiatr Developments 1987; 1:1-23
2. Pilgrim C, Reisert I: Differences between male and female brains - developmental mechanisms and implications. Horm Metab Res 1992; 24:353-359
3. Breedlove SM: Sexual differentiation of the human nervous system, in Annual Review of Psychology. Edited by Porter LW, Rosenzweig MR. Palo Alto, Calif, Annual Reviews, 1994, pp 389-418
4. Finegan J, Bartleman B, Wong PY: A window for the study of prenatal sex hormone influences on postnatal development. J Genet Psychol 1988; 150:101-112
5. Rubinow DR, Schmidt PJ: Androgens, brain, and behavior. Am J Psychiatry 1996; 153:974-984
6. Caswell H, Weeks DE: Two-sex models: chaos, extinction, and other dynamic consequences of sex. American Naturalist 1986; 128:707-735
7. Bachman DL, Wolf PA, Linn R, Knoefel JE, Cobb J, Belanger A, D'Agostino RB, White LR: Prevalence of dementia and probable senile dementia of the Alzheimer type in the Framingham Study. Neurology 1992; 42:115-119
8. Bachman DL, Wolf PA, Linn RT, Knoefel JE, Cobb JL, Belanger AJ, White LR, D'Agostino RB: Incidence of dementia and probable Alzheirner's disease in a general population: the Framingham Study. Neurology 1993; 43:515-519
9. Canadian Study of Health and Aging Working Group: Canadian study of health and aging: study methods and prevalence of dementia. Can Med Assoc J 1994; 150:899-913
10. Tang MX, Jacobs D, Stern Y, Marder K, Schofield P, Gurland B, Andrews H, Mayeux R: Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet 1996; 348:429-432
11. Henderson VW, Buckwalter JG: Cognitive deficits of men and women with Alzheimer's disease. Neurology 1994; 44:90-96
12. McEwen BS: Non-genomic and genomic effects of steroids on neural activity. Trends Pharmacol Sci 1991; 12:141-147
13. Paganini-Hill A, Henderson VW: Estrogen replacement therapy and risk of Alzheimer's disease. Arch Intern Med 1996; 156: 2213-2217
14. Henderson VW, Paganini-Hill A, Emanuel CK, Dunn ME, Buckwalter JG: Estrogen replacement therapy in older women. Arch Neurol 1994; 51:896-900
15. Goodman Y, Bruce AJ, Cheng B, Mattson MP: Estrogens attenuate and corticosterone exacerbates excitotoxicity, oxidative injury and amyloid B-peptide toxicity of hippocampal neurons. J Neurochem 1996; 66:1836-1844
16. Wickelgren I: Estrogen stakes claim to cognition. Science 1997; 276:675-678
17. McEwen BS: Steroid hormones are multifunctional messengers to the brain. Trends in Endocrinology and Metabolism 1991; 2:62-67
18. Häfner H, an der Heiden W: Epidemiology of schizophrenia. Can J Psychiatry 1997; 42:139-151
19. Lewine RJR, Seeman MV: Gender, brain, and schizophrenia: anatomy of differences/differences of anatomy, in Gender and Psychopathology. Edited by Seeman MV. Washington, DC, American Psychiatric Press, 1995, pp 131-158
20. Jablensky A, Cole SW: Is the earlier age at onset of schizophrenia in males a confounded finding? Br J Psychiatry 1997; 170:234-240
21. Ciompi L: The influence of aging on schizophrenia. Triangle 1993; 32:25-31
22. Wong DF, Wagner HN Jr, Dannals RF, Links JM, Frost JJ, Ravert HT, Wilson AA, Rosenbaum AE, Gjedde A, Douglass KH, Petronis JD, Folstein MF, Toung JKT, Burns HD, Kuhar MJ: Effects of age on dopamine and serotonin receptors measured by positron tomography in the living human brain. Science 1984; 226:1393-1396
23. Seeman MV: Sex differences in predicting neuroleptic response, in The Prediction of Neuroleptic Response. Edited by Gaebel W, Awad AG. Vienna, Springer-Verlag, 1995, pp 51-64
24. Blum M, McEwen BS, Roberts JL: Transcriptional analysis of tyrosine hydroxylase gene expression in the tuberoinfundibular dopaminergic neurons of the rat arcuate nucleus after estrogen treatment. J Biol Chem 1987; 262:817-821
25. DiPaolo T: Modulation of brain dopamine transmission by sex steroids. Rev Neurosci 1994; 5:27-42
26. Castle DJ, Abel K, Takei N, Murray RM: Gender differences in schizophrenia: hormonal effect or subtypes? Schizophr Bull 1995; 21:1-12
27. Faraone SV, Chen WJ, Goldstein JM, Tsuang MT: Gender differences in age at onset of schizophrenia. Br J Psychiatry 1994; 164:625-629
28. Albus M, Maier W: Lack of gender differences in age at onset in familial schizophrenia. Schizophr Res 1995; 18:51-57
29. DeLisi LE: Age of onset in familial schizophrenia. Arch Gen Psychiatry 1994; 51:334-335
30. Gorwood P, Leboyer M, Jay M, Payan C, Feingold J: Gender and age at onset in schizophrenia: impact of family history. Am J Psychiatry 1995; 152:208-212
31. Aida M, Ahrens B, Lit W, Dvorakova M, Labelle A, Zvolsky P, Jones B: Age of onset in familial and sporadic schizophrenia. Acta Psychiatr Scand 1996; 93:447-450
32. Kendler KS, Karkowski-Shuman L, Walsh D: Age at onset in schizophrenia and risk of illness in relatives: results from the Roscommon family study. Br J Psychiatry 1996; 169:213-218
33. Hultman CM, Ohman A, Cnattingius S, Wieselgren IM, Lindstrom LH: Prenatal and neonatal risk factors for schizophrenia. Br J Psychiatry 1997; 170:128-133
34. Shtasel DL, Gur RE, Gallacher F, Heimberg C, Gur RC: Gender differences in the clinical expression of schizophrenia. Schizophr Res 1992; 7:225-231
35. Gur RE, Petty RG, Turetsky BI,Gur RC: Schizophrenia throughout life: sex differences in severity and profile of symptoms. Schizophr Res 1996; 21:1-12
36. Cowell PE, Kostianovsky DJ, Gur RC, Turesky BI, Gur RE: Sex differences in neuroanatomical and clinical correlations in schizophrenia. Am J Psychiatry 1996; 153:799-805
37. Reite M, Sheeder J, Teale P, Adams M, Richardson D, Simon J, Jones RH, Rojas DC: Magnetic source imaging evidence of sex differences in cerebral lateralization in schizophrenia. Arch Gen Psychiatry 1997; 54:433-440
38. Schlaepfer TE, Harris GJ, Tien AY, Peng LW, Lee S, Federman EB, Chase GA, Barta PE, Pearlson GD: Decreased regional cortical gray matter volume in schizophrenia. Am J Psychiatry 1994; 151:842-848
39. Lewis DW, Diamond MC: The influence of gonadal steroids on the asymmetry of the cerebral cortex, in Brain Asymmetry. Edited by Davidson RJ, Hugdahl K. Cambridge, Mass, MIT Press, 1995, pp 31-50
40. Seeman MV, Lang M: The role of estrogens in schizophrenia gender differences. Schizophr Bull 1990; 16:185-194
41. Seeman MV: The role of estrogen in schizophrenia. J Psychiatry Neurosci 1996; 21:123-127
42. Toran-Allerand CD: The estrogen/neurotrophin connection during neural development: is co-localization of estrogen receptors with the neurotrophins and their receptors biologically relevant? Dev Neurosci 1996; 18:36-41
43. Castle DJ, Murray RM: The epidemiology of late-onset schizophrenia. Schizophr Bull 1993; 19:691-700
44. Howard R, Almeida O, Levy R: Phenomenology, demography and diagnosis in late paraphrenia. Psychol Med 1994; 24:397-410
45. Pearlson G, Rabins P: The late-onset psychoses: possible risk factors. Psychiatr Clin North Am 1988; 11:15-32
46. Salokangas RKR: Gender and the use of neuroleptics in schizophrenia: further testing of the oestrogen hypothesis. Schizophr Res 1995; 16:7-16
47. Häfner H, Behrens S, De Vry J, Gattaz WF: An animal model for the effects of estradiol on dopamine-mediated behavior: implications for sex differences in schizophrenia. Psychiatry Res 1991; 38:125-134
48. Häfner H, Behrens S, De Vry J, Gattaz WF: Oestradiol enhances the vulnerability threshold for schizophrenia in women by an early effect on dopaminergic transmission. Eur Arch Psychiatry Clin Neurosci 1991; 241:65-68
49. Riecher-Rössler A, Häfner H: Schizophrenia and oestrogens - is there an association? Eur Arch Psychiatry Clin Neurosci 1993; 242:323-328
50. Lewis DA: Development of the prefrontal cortex during adolescence: insights into vulnerable neural circuits in schizophrenia. Neuropsychopharmacology 1997; 16:385-398
51. Lewine RRJ: Gender and schizophrenia, in Handbook of Schizophrenia, vol 3. Edited by Tsuang M, Simpson J. Amsterdam, Elsevier, 1988, pp 131-158
52. Foerster A, Lewis S, Owen M, Murray R: Pre-morbid adjustment and personality in psychosis: effects of sex and diagnosis. Br J Psychiatry 1991; 158:171-176
53. Mueser KT, Bellack AS, Morrison RL, Wixted JT: Social competence in schizophrenia: premorbid adjustment, social skill, and domains of functioning. J Psychiatr Res 1990; 24:51-63
54. Häfner H, Nowotny B, Loffler W, an der Heiden W, Maurer K: When and how does schizophrenia produce social deficits? Eur Arch Psychiatry Clin Neurosci 1995; 246:17-28
55. Harrison G, Croudace P, Mason C, Glazebrook C, Medley I: Predicting the long-term outcome of schizophrenia. Psychol Med 1996; 26:697-705
56. Jonsson H, Nyman AK: Predicting long-term outcome in schizophrenia. Acta Psychiatr Scand 1991; 83:342-346
57. Opjordsmoen S: Long-term clinical outcome of schizophrenia with special reference to gender differences. Acta Psychiatr Scand 1991; 83:307-313
58. Salokangas RKR, Stengard E: Gender and short-term outcome in schizophrenia. Sehizophr Res 1990; 3:333-345
59. Chang SS, Renshaw DC: Psychosis and pregnancy. Compr Ther 1986; 12:36-41
60. Krener P, Simmons MK, Hansen RL, Treat JN: Effect of pregnancy on psychosis: life circumstances and psychiatric symptoms. Int J Psychiatry Med 1989; 19:65-84
61. Kendell RE, Chalmers JC, Platz C: Epidemiology and puerperal psychoses, Br J Psychiatry 1987; 150:662-673
62. Gattaz WF, Vogel P, Riecher-Rössler A, Soddu G: Influence of the menstrual cycle phase on the therapeutic response in schizophrenia. Biol Psychiatry 1994; 36:137-139
63. Hallonquist J, Seeman MV, Lang M, Rector N: Variation in symptom severity over the menstrual cycle of schizophrenics. Biol Psychiatry 1993; 33:207-209
64. Riecher-Rössler A, Häfner H, Stumbaum M, Maurer K, Schmidt R: Can estradiol modulate schizophrenic symptomatology? Schizophr Bull 1994; 20:203-214
65. Kulkarni J, de Castella A, Smith D, Taffe J, Keks N, Copolov D: A clinical trial of the effects of estrogen in acutely psychotic women. Schizophr Res 1996; 20:247-252
66. Lex B: Gender differences and substance abuse. Advances in Substance Abuse 1991; 4:225-296
67. Lakota GN, Barkov NK: The role of testosterone in the development of experimental alcoholism. Bull Narc 1980; 32:41-48
68. Lex BW: Alcohol and other psychoactive substance dependence in men and women, in Gender and Psychopathology. Edited by Seeman MV, Washington, DC, American Psychiatric Press, 1995. pp 311-358
69. Greenfield SF: Women and substance use disorders, in Psychopharmacology and Women. Edited by Jensvold MF, Halbreich U, Hamilton JA. Washington, DC, American Psychiatric Press, 1996. pp 299-321
70. Bland RC, Newman SC, Orn H: Epidemiology of psychiatric disorders in Edmonton. Acta Psychiatr Scand Suppl 1988; 338:1-80
71. Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, Wittchen H, Kendler KS: Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: results from the National Comorbidity Survey. Arch Gen Psychiatry 1994; 51:8-19
72. Offord DR, Boyle MH, Campbell D, Goering P, Lin E, Wong M, Racine Y: One-year prevalence of psychiatric disorder in Ontarians 15 to 64 years of age. Can J Psychiatry 1996; 41:559-563
73. Robins LN, Regier DA (eds): Psychiatric Disorders in America: The Epidemiologic Catchment Area Study. New York, Free Press, 1991
74. Wolpe J, Lang P: A fear survey schedule for use in behavior therapy. Behav Res Ther 1964; 2:27-30
75. Yonkers KA, Gurguis G: Gender differences in the prevalence and expression of anxiety disorders, in Gender and Psychopathology. Edited by Seeman MV, Washington, DC, American Psychiatric Press, 1995, pp 113-130
76. Yonkers KA, Ellison JM: Anxiety disorders in women and their pharmacological treatment, in Psychopharmacology and Women. Edited by Jensvold MF, Halbreich U, Hamilton JA, Washington, DC, American Psychiatric Press, 1996, pp 261-285
77. Mnjewska MD: Neurosteroids: endogenous modulators of the GABA-A receptor; mechanism of action and physiological significance. Prog Neurobiol 1992; 38:379-395
78. Maggi A, Perez J: Estrogen-induced up-regulation of gamma-amino butyric receptors in the CNS of rodents. J Neurochem 1986; 47:1793-1797
79. Narbone MC, Ruello C, Oliva A, Baviera G, D'Amico D, Bramanti P, Di Perri R: Hormonal dysregulation and catamenial epilepsy. Funct Neurol 1990; 5:49-53
80. Kessler RC, McGonagle KA, Swartz M, Blazer DG, Nelson CB: Sex and depression in the National Comorbidity Survey, I: lifetime prevalence, chronicity and recurrence. J Affect Disord 1993; 29:85-96
81. Buchanan CM, Becker JB, Eccles JS: Are adolescents the victims of raging hormones? evidence for activational effects of hormones on moods and behavior at adolescence. Psychol Bull 1992; 111:62-107
82. Woodside DB, Kennedy SH: Gender differences in eating disorders, in Gender and Psychopathology, Edited by Seeman MV. Washington, DC, American Psychiatric Press, 1995, pp 253-268
83. McDermott JF Jr, Robillard AB, Char WF, Hsu J, Tseng WS, Ashton GC: Reexamining the concept of adolescence: differences between adolescent boys and girls in the context of their families. Am J Psychiatry 1983; 140:1318-1322
84. Almqvist F: Sex differences in adolescent psychopathology. Acta Psychiatr Scand 1986; 73:295-306
85. Shaw J, Kennedy SH, Joffe RT: Gender differences in mood disorders: a clinical focus, in Gender and Psychopathology. Edited by Seeman MV. Washington, DC, American Psychiatric Press, 1995, pp 89-111
86. Levav I, Kohn R, Golding JM, Weissman MM: Vulnerability of Jews to affective disorders. Am J Psychiatry 1997; 154:941-947
87. Harris T, Surtees P, Bancroft J: Is sex necessarily a risk factor for depression? Br J Psychiatry 1991; 158:708-712
88. Paykel ES: Depression in women. Br J Psychiatry 1991; 158 (suppl 10):22-29
89. Silverstein B, Perlick D: Gender differences in depression: historical changes. Acta Psychiatr Scand 1991; 84:327-331
90. Hamilton JA, Grant M, Jensvold MF: Sex and treatment of depressions: when does it matter? in Psychopharmacology and Women. Edited by Jensvold MF, Halbreich U, Hamilton JA. Washington, DC, American Psychiatric Press, 1996, pp 241-257
91. Brown LS, Ballou M: Personality and Psychopathology: Feminist Reappraisals. New York, Guilford Press, 1992
92. Boyce P, Parker G, Barnett B, Cooney M, Smith F: Personality as a vulnerability factor to depression. Br J Psychiatry 1991; 159:106-114
93. Cohen S, Wills TA: Stress, social support, and the buffering hypothesis. Psychol Bull 1985; 98:310-357
94. Nolen-Hoeksema S: Sex Differences in Depression. Stanford, Calif, Stanford University Press, 1990
95. Schumaker M, Baulieu EE: Neurosteroids: synthesis and function in the central and peripheral nervous systems. Ciba Found Symp 1995; 191:90-106
96. Mizoguchi K, Tatshuhide T, De-Hua C, Tabira T: Stress induces neuronal death in the hippocampus of castrated rats. Neurosci Lett 1991; 138:157-160
97. Miranda RC, Sohrabji F: Gonadal steroid receptors: possible roles in the etiology and therapy of cognitive and neurological disorders. Annual Reports in Medicinal Chemistry 1996; 31: 11-20
98. Sohrabji F, Miranda RC, Toran-Allerand CD: Estrogen differentially regulates estrogen and nerve growth factor receptor mRNAs in adult sensory neurons. J Neurosci 1994; 14:459-471
99. Sapolsky RM: Stress, glucocorticoids, and damage to the nervous system: the current state of confusion. Stress 1996; 1:1-19
100. Kendler KS, Kessler RC, Neale MC, Heath AC, Eaves LJ: The prediction of major depression in women: toward an integrated etiologic model. Am J Psychiatry 1993; 150:1139-1148